Checkpoint Therapeutics Share Price Today
(NASDAQ: CKPT)

Name: Checkpoint Therapeutics Share Price Today (NASDAQ: CKPT) - Checkpoint Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Checkpoint Therapeutics share price is $4.1 & ₹350.38 as on 26 Apr 2025, 2.30 'hrs' IST

$4.1

▲

0.01

(0.24%)

Market is closed - opens 7 PM, 28 Apr 2025

View live Checkpoint Therapeutics share price in Dollar and Rupees. Guide to invest in Checkpoint Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Checkpoint Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Checkpoint Therapeutics share price movements

Today's Low: $4.08
Today's High: $4.10
$4.10
0.49%
Downside
Day's Volatility :0.49%
Upside
0.0%
52 Weeks Low: $1.38
52 Weeks High: $4.50
$4.10
66.34%
Downside
52 Weeks Volatility :69.33%
Upside
8.89%

Checkpoint Therapeutics (CKPT) Returns

Period	Checkpoint Therapeutics Inc	Index (Russel 2000)
3 Months	42.68%	0.0%
6 Months	11.28%	0.0%
1 Year	185.37%	0.0%
3 Years	-67.24%	-6.1%

Checkpoint Therapeutics (CKPT) Key Statistics

in dollars & INR

Previous Close	$4.09
Open	$4.08
Today's High	$4.1
Today's Low	$4.08
Market Capitalization	$355.9M
Today's Volume	$1.3M
52 Week High	$4.5
52 Week Low	$1.38
Revenue TTM	$41.0K
Earnings Per Share (EPS)	$-1.42
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1220.38%

How to invest in Checkpoint Therapeutics Stock (CKPT) from India?

It is very easy for Indian residents to invest directly in Checkpoint Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Checkpoint Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Checkpoint Therapeutics or CKPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Checkpoint Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Checkpoint Therapeutics shares which would translate to 0.208 fractional shares of Checkpoint Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Checkpoint Therapeutics, in just a few clicks!

Returns in Checkpoint Therapeutics (CKPT) for Indian investors in Rupees

The Checkpoint Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Checkpoint Therapeutics investment value today

Current value as on today

₹2,87,280

Returns

₹1,87,280

(+187.28%)

Returns from Checkpoint Therapeutics Stock

₹1,84,722 (+184.72%)

Dollar Returns

₹2,558 (+2.56%)

Indian investors sentiment towards Checkpoint Therapeutics (CKPT)

-96%

Period: Mar 27, 2025 to Apr 26, 2025. Change in 30 Days versus previous period

Search interest for Checkpoint Therapeutics Stock from India on INDmoney has decreased by -96% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Checkpoint Therapeutics

Armistice Capital, LLC
5.33%
Vanguard Group Inc
2.27%
Susquehanna International Group, LLP
0.57%
Geode Capital Management, LLC
0.53%
Wealth Enhancement Advisory Services, LLC
0.51%
Kestra Advisory Services, LLC
0.39%

Analyst Recommendation on Checkpoint Therapeutics

Rating

Trend

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Checkpoint Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Checkpoint Therapeutics Stock (CKPT)

What analysts predicted

Upside of 5.69%

Target:

$4.33

Current:

$4.10

Insights on Checkpoint Therapeutics Stock (Ticker Symbol: CKPT)

Price Movement
In the last 3 months, CKPT stock has moved up by 42.7%
Increasing Revenue
Revenue is up for the last 2 quarters, 6.0K → 41.0K (in $), with an average increase of 85.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -6.67M → -28.9M (in $), with an average decrease of 121.5% per quarter
CKPT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 62.5% return, outperforming this stock by 128.7%

Checkpoint Therapeutics Technicals Summary

Sell

Neutral

Buy

Checkpoint Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Checkpoint Therapeutics (CKPT) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Checkpoint Therapeutics Inc	1.61%	11.28%	185.37%	-67.24%	-77.12%
Regeneron Pharmaceuticals, Inc.	-5.48%	-35.12%	-32.5%	-10.82%	13.97%
Beone Medicines Ltd	-8.49%	12.64%	56.32%	54.42%	50.0%
Vertex Pharmaceuticals Incorporated	0.24%	3.67%	24.65%	83.83%	92.19%
Alnylam Pharmaceuticals, Inc.	-6.24%	-12.27%	70.81%	75.82%	83.05%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Checkpoint Therapeutics Inc	NA	NA	0.0	0.27	-12.2	-5.46	NA	-0.23
Regeneron Pharmaceuticals, Inc.	15.65	15.65	0.96	39.99	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.35	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Checkpoint Therapeutics Inc	Buy	$355.9M	-77.12%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$65.6B	13.97%	15.65	31.07%
Beone Medicines Ltd	NA	$29.1B	50.0%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$126.6B	92.19%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	83.05%	NA	-12.37%

About Checkpoint Therapeutics

Checkpoint Therapeutics, Inc., a commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. The company's lead antibody product candidate is UNLOXCYT, which is in Phase 1 clinical trial to treat patients with selected recurrent or metastatic cancers; and CK-302, a product candidate in preclinical trials for hematological malignancies and solid tumors. It also developing Olafertinib, which is in Phase 3 clinical trials for the treatment of adult patients with metastatic non-small cell lung cancer; CK-103 for the treatment of various advanced and metastatic solid tumor cancers; and Anti-Carbonic Anhydrase IX (CAIX) antibody, a product candidate in preclinical trials to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. It has licensing and collaboration agreements with Adimab, LLC for the development of Cosibelimab; NeuPharma, Inc., to develop and commercialize Olafertinib; and Jubilant Biosys Limited for the development and commercialization of novel compounds that inhibit BET bromodomains, as well as collaboration with Dana-Farber Cancer Institute, Inc. Checkpoint Therapeutics, Inc. was incorporated in 2014 and is based in Waltham, Massachusetts.

Organization	Checkpoint Therapeutics
Employees	24
CEO	Mr. James F. Oliviero III, C.F.A.
Industry	Health Technology

Management People of Checkpoint Therapeutics

Name	Title
Mr. James F. Oliviero III, C.F.A.	President, CEO & Director

Important FAQs about investing in CKPT Stock from India :

What is Checkpoint Therapeutics share price today?

Checkpoint Therapeutics share price today stands at $4.10, Open: $4.08 ; Previous Close: $4.09 ; High: $4.10 ; Low: $4.08 ; 52 Week High: $4.50 ; 52 Week Low: $1.38.

The stock opens at $4.08, after a previous close of $4.09. The stock reached a daily high of $4.10 and a low of $4.08, with a 52-week high of $4.50 and a 52-week low of $1.38.

Can Indians buy Checkpoint Therapeutics shares?

Yes, Indians can invest in the Checkpoint Therapeutics (CKPT) from India.

With INDmoney, you can buy Checkpoint Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Checkpoint Therapeutics at zero transaction cost.

How can I buy Checkpoint Therapeutics shares from India?

It is very easy to buy Checkpoint Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Checkpoint Therapeutics (CKPT) be purchased?

Yes, you can buy fractional shares of Checkpoint Therapeutics with INDmoney app.

What are the documents required to start investing in Checkpoint Therapeutics stocks?

To start investing in Checkpoint Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.